Mapping Lyme bacteria for better patient care

A genetic analysis of Lyme disease bacteria may pave the way for improved diagnosis, treatment and prevention of the tick-borne ailment.

Illumina receives EU clearance for planned Grail divestment

Illumina and Grail are another step closer to ending their yearslong antitrust saga. The European Commission has approved Illumina’s divestment plan for Grail, the cancer

April 13, 2024

Q/A: AiCure SVP Talks Improving Access to Clinical Trials

Sondra Pepe, SVP of Product Management, at AiCure The imperative to enhance access to quality care and research is a central concern gripping both the

August 7, 2023

AGEPHA Pharma’s LODOCO receives US FDA approval

LODOCO is indicated for reducing the risk of stroke, myocardial infarction and cardiovascular death in adult ASCVD patients. Credit: AGEPHA Pharma/ Business Wire. AGEPHA Pharma

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.